Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Reaches Deal for $1.5B Credit Facility

NEW YORK – PerkinElmer said after the close of the market on Wednesday that it has entered into an agreement for a new $1.5 billion revolving credit facility.

The agreement provides for the unsecured revolving credit facility through Aug. 24, 2026, and replaces an unsecured revolving credit agreement dated Sept. 17, 2019, which provided for a $1 billion unsecured revolving credit facility.

Bank of America was the administrative agent, swing line lender, and line of credit issuer on the transaction. Other lenders included Goldman Sachs Bank USA, JP Morgan Chase Bank, and Wells Fargo Bank NA.

Earlier this month, Waltham, Massachusetts-based PerkinElmer reached an agreement for a $500 million credit facility to help pay for its $5.25 billion acquisition of BioLegend.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.